Reports for BAXTER CORPORATION
Company Name
BAXTER CORPORATION
Totals |
||
Shortage reports |
233 |
|
| Actual shortage: | 5 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 3 (1%) | |
| Resolved: | 223 (96%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 2 (7%) | |
| Discontinued: | 27 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
14 (5%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-02-25 | 2022-03-26 | 155672 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2022-08-31 | 2022-11-02 | 168276 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 300MG 900MG 5G | SOLUTION | Resolved | 2025-01-08 | 2025-05-31 | 247098 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-01-12 | 2018-02-06 | 35770 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-08-13 | 2018-08-29 | 58038 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2018-12-14 | 2018-12-20 | 69676 |
| POTASSIUM CHLORIDE INJECTION | 7.46MG | LIQUID | Resolved | 2019-07-16 | 2019-11-29 | 89426 |
| POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-01-25 | 2019-02-05 | 73584 |
| POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-03-01 | 2019-03-07 | 77248 |
| POTASSIUM CHLORIDE INJECTION | 14.9MG | LIQUID | Resolved | 2019-09-20 | 2019-11-01 | 94470 |
| POTASSIUM CHLORIDE INJECTION | 20mEq | SOLUTION LIQUID | Resolved | 2024-02-02 | 2024-02-15 | 218224 |
| POTASSIUM CHLORIDE INJECTION | 29.8MG | LIQUID | Resolved | 2018-10-02 | 2018-10-18 | 62874 |
| POTASSIUM CHLORIDE INJECTION | 29.8MG | LIQUID | Resolved | 2019-11-08 | 2019-11-29 | 98262 |
| PRIMENE 10% | 318MG 300MG 400MG 400MG 600MG 800MG 840MG 1G 45MG 60MG 200MG 240MG 189MG 370MG 380MG 420MG 670MG 760MG 1.1G 1G | LIQUID | Resolved | 2023-04-24 | 2023-10-16 | 190244 |
| PROCYTOX | 2000MG | POWDER FOR SOLUTION | Resolved | 2024-01-29 | 2024-02-28 | 217583 |
| PROCYTOX | 2000MG | POWDER FOR SOLUTION | Resolved | 2024-04-19 | 2024-05-03 | 225670 |
| PROCYTOX TAB 25MG | 25MG | TABLET | Resolved | 2017-04-06 | 2017-08-29 | 5778 |
| PROCYTOX TAB 25MG | 25MG | TABLET | Resolved | 2019-03-04 | 2019-03-16 | 77345 |
| PROCYTOX TAB 25MG | 25MG | TABLET | Resolved | 2022-06-03 | 2022-07-11 | 161841 |
| PROCYTOX TAB 50MG | 50MG | TABLET | Resolved | 2022-02-25 | 2022-04-14 | 155663 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLINIMIX E | 90MG 210MG 20MG 261MG 58.5MG 24MG 205MG 20G 310MG 310MG 290MG 290MG 1.04G 1.04G 520MG 240MG 230MG 220MG 210MG | SOLUTION | Discontinued | 2020-06-22 | 2021-03-26 | 118604 |
| CLINIMIX E | 205MG 261MG 58.5MG 24MG 16.6G 365MG 280MG 290MG 200MG 300MG 290MG 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG | SOLUTION | Discontinued | 2020-06-22 | 2022-06-30 | 118607 |
| CLINOLEIC 20% | 4% 16% | EMULSION | Discontinued | 2017-04-04 | 2018-01-01 | 5289 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91378 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91382 |
| NUTRINEAL PD4 | 57MG 71.4MG 27MG 102MG 107.1MG 448MG 64.6MG 95.1MG 5.1MG 18.4MG 538MG 85MG 51MG 59.5MG 30MG 95.5MG 51MG 139.3MG 85MG | LIQUID | Discontinued | 2019-08-12 | 2020-06-02 | 91385 |
| POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR | 5G 900MG 300MG | SOLUTION | Discontinued | 2020-11-26 | 2021-02-02 | 128947 |
| PROCYTOX | 200MG | POWDER FOR SOLUTION | To be discontinued | 2025-08-14 | 2025-08-14 | 265253 |
| PROCYTOX TAB 25MG | 25MG | TABLET | To be discontinued | 2025-08-14 | 2025-08-14 | 265250 |